Mark Alan Smith

Insider Reports History

Entity
Individual
Location
343 Allerton Avenue, South San Francisco, CA
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Alan Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VistaGen Therapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 19.9K $34.2K $1.72 Jun 30, 2022 Direct

Insider Reports Filed by Mark Alan Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTGN VistaGen Therapeutics, Inc. Jun 30, 2022 1 $3.74K 4 Jul 15, 2022 CHIEF MEDICAL OFFICER
VTGN VistaGen Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 CHIEF MEDICAL OFFICER
VTGN VistaGen Therapeutics, Inc. Dec 31, 2021 1 $4.4K 4 Jan 3, 2022 CHIEF MEDICAL OFFICER
VTGN VistaGen Therapeutics, Inc. Jun 30, 2021 1 $4.4K 4 Jul 2, 2021 CHIEF MEDICAL OFFICER